Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells

Yong Ko, Sunandita S. Banerji, Yu Liu, Wenhui Li, Jiurong Liang, Herbert D. Soule, Robert J. Pauley, James K.V. Willson, Elizabeth Zborowska, Michael G Brattain

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

To analyze transforming growth factor-β (TGF-β) response during MCF-7 cell progression, early passage (MCF-7E, <200 passage) and late passage (MCF- 7L, > 500 passage) cells were compared. MCF-7E cells showed an IC50 of ~ 10 ng/ml of TGF-β1, whereas MCF-7L cells were insensitive, MCF-7E cells contained approximately threefold higher levels of TGF-β receptor type II (TβRII) mRNA than MCF-7L, but their TβRI levels were similar, MCF-7E parental cells showed higher TβRI promoter activity than MCF-7L cells, which could be attributed to changes in Sp1 nuclear protein levels. Receptor cross- linking studies indicated that the cell surface receptor levels parallel mRNA levels in both cell lines. Limiting dilution clones MCF-7E cells were established to determine the heterogenecity of TβRII expression in this cell line, and they showed varying degrees of TβRII expression. Fibronectin was induced at higher levels in cells expressing higher TβRII levels. All three TGF-β isoforms were detected in limiting dilution clones and parental cells, but TGF-β1 was more abundant relative to TGF-β2 or 3, and no correlation between TGF-β isoform profile with TGF-β sensitivity was found. MCF-7l cells were tumorigenic and formed xenografts rapidly and progressively, whereas MCF-7E parental and limiting dilution clonal cells showed transient tumor formation followed by regression. These results indicate that decrease TβRII transcription in breast cancer cells leads to loss of TβRII expression resulting in cellular resistance to TGF-β which contributes to escape from negative growth regulation and tumor progression.

Original languageEnglish (US)
Pages (from-to)424-434
Number of pages11
JournalJournal of Cellular Physiology
Volume176
Issue number2
DOIs
StatePublished - Aug 1 1998

Fingerprint

Growth Factor Receptors
MCF-7 Cells
Transforming Growth Factors
Adenocarcinoma
Breast
Cells
Dilution
Tumors
Protein Isoforms
Clone Cells
Messenger RNA
Cell Surface Receptors
Transcription
Cell Line
Nuclear Proteins
Fibronectins
Heterografts
Crosslinking
Inhibitory Concentration 50
Neoplasms

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. / Ko, Yong; Banerji, Sunandita S.; Liu, Yu; Li, Wenhui; Liang, Jiurong; Soule, Herbert D.; Pauley, Robert J.; Willson, James K.V.; Zborowska, Elizabeth; Brattain, Michael G.

In: Journal of Cellular Physiology, Vol. 176, No. 2, 01.08.1998, p. 424-434.

Research output: Contribution to journalArticle

Ko, Yong ; Banerji, Sunandita S. ; Liu, Yu ; Li, Wenhui ; Liang, Jiurong ; Soule, Herbert D. ; Pauley, Robert J. ; Willson, James K.V. ; Zborowska, Elizabeth ; Brattain, Michael G. / Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells. In: Journal of Cellular Physiology. 1998 ; Vol. 176, No. 2. pp. 424-434.
@article{098317fe5cf74c2683f4136deb3351b3,
title = "Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells",
abstract = "To analyze transforming growth factor-β (TGF-β) response during MCF-7 cell progression, early passage (MCF-7E, <200 passage) and late passage (MCF- 7L, > 500 passage) cells were compared. MCF-7E cells showed an IC50 of ~ 10 ng/ml of TGF-β1, whereas MCF-7L cells were insensitive, MCF-7E cells contained approximately threefold higher levels of TGF-β receptor type II (TβRII) mRNA than MCF-7L, but their TβRI levels were similar, MCF-7E parental cells showed higher TβRI promoter activity than MCF-7L cells, which could be attributed to changes in Sp1 nuclear protein levels. Receptor cross- linking studies indicated that the cell surface receptor levels parallel mRNA levels in both cell lines. Limiting dilution clones MCF-7E cells were established to determine the heterogenecity of TβRII expression in this cell line, and they showed varying degrees of TβRII expression. Fibronectin was induced at higher levels in cells expressing higher TβRII levels. All three TGF-β isoforms were detected in limiting dilution clones and parental cells, but TGF-β1 was more abundant relative to TGF-β2 or 3, and no correlation between TGF-β isoform profile with TGF-β sensitivity was found. MCF-7l cells were tumorigenic and formed xenografts rapidly and progressively, whereas MCF-7E parental and limiting dilution clonal cells showed transient tumor formation followed by regression. These results indicate that decrease TβRII transcription in breast cancer cells leads to loss of TβRII expression resulting in cellular resistance to TGF-β which contributes to escape from negative growth regulation and tumor progression.",
author = "Yong Ko and Banerji, {Sunandita S.} and Yu Liu and Wenhui Li and Jiurong Liang and Soule, {Herbert D.} and Pauley, {Robert J.} and Willson, {James K.V.} and Elizabeth Zborowska and Brattain, {Michael G}",
year = "1998",
month = "8",
day = "1",
doi = "10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1",
language = "English (US)",
volume = "176",
pages = "424--434",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells

AU - Ko, Yong

AU - Banerji, Sunandita S.

AU - Liu, Yu

AU - Li, Wenhui

AU - Liang, Jiurong

AU - Soule, Herbert D.

AU - Pauley, Robert J.

AU - Willson, James K.V.

AU - Zborowska, Elizabeth

AU - Brattain, Michael G

PY - 1998/8/1

Y1 - 1998/8/1

N2 - To analyze transforming growth factor-β (TGF-β) response during MCF-7 cell progression, early passage (MCF-7E, <200 passage) and late passage (MCF- 7L, > 500 passage) cells were compared. MCF-7E cells showed an IC50 of ~ 10 ng/ml of TGF-β1, whereas MCF-7L cells were insensitive, MCF-7E cells contained approximately threefold higher levels of TGF-β receptor type II (TβRII) mRNA than MCF-7L, but their TβRI levels were similar, MCF-7E parental cells showed higher TβRI promoter activity than MCF-7L cells, which could be attributed to changes in Sp1 nuclear protein levels. Receptor cross- linking studies indicated that the cell surface receptor levels parallel mRNA levels in both cell lines. Limiting dilution clones MCF-7E cells were established to determine the heterogenecity of TβRII expression in this cell line, and they showed varying degrees of TβRII expression. Fibronectin was induced at higher levels in cells expressing higher TβRII levels. All three TGF-β isoforms were detected in limiting dilution clones and parental cells, but TGF-β1 was more abundant relative to TGF-β2 or 3, and no correlation between TGF-β isoform profile with TGF-β sensitivity was found. MCF-7l cells were tumorigenic and formed xenografts rapidly and progressively, whereas MCF-7E parental and limiting dilution clonal cells showed transient tumor formation followed by regression. These results indicate that decrease TβRII transcription in breast cancer cells leads to loss of TβRII expression resulting in cellular resistance to TGF-β which contributes to escape from negative growth regulation and tumor progression.

AB - To analyze transforming growth factor-β (TGF-β) response during MCF-7 cell progression, early passage (MCF-7E, <200 passage) and late passage (MCF- 7L, > 500 passage) cells were compared. MCF-7E cells showed an IC50 of ~ 10 ng/ml of TGF-β1, whereas MCF-7L cells were insensitive, MCF-7E cells contained approximately threefold higher levels of TGF-β receptor type II (TβRII) mRNA than MCF-7L, but their TβRI levels were similar, MCF-7E parental cells showed higher TβRI promoter activity than MCF-7L cells, which could be attributed to changes in Sp1 nuclear protein levels. Receptor cross- linking studies indicated that the cell surface receptor levels parallel mRNA levels in both cell lines. Limiting dilution clones MCF-7E cells were established to determine the heterogenecity of TβRII expression in this cell line, and they showed varying degrees of TβRII expression. Fibronectin was induced at higher levels in cells expressing higher TβRII levels. All three TGF-β isoforms were detected in limiting dilution clones and parental cells, but TGF-β1 was more abundant relative to TGF-β2 or 3, and no correlation between TGF-β isoform profile with TGF-β sensitivity was found. MCF-7l cells were tumorigenic and formed xenografts rapidly and progressively, whereas MCF-7E parental and limiting dilution clonal cells showed transient tumor formation followed by regression. These results indicate that decrease TβRII transcription in breast cancer cells leads to loss of TβRII expression resulting in cellular resistance to TGF-β which contributes to escape from negative growth regulation and tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=0031874414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031874414&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1

DO - 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1

M3 - Article

VL - 176

SP - 424

EP - 434

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -